Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells

Breast cancer is the second leading cause of death in women, and tamoxifen citrate (TMX) is accepted widely for the treatment of hormone receptor–positive breast cancers. Several local drug-delivery systems, including nanofibers, have been developed for antitumor treatment. Nanofibers are biomateria...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinzón-García, Ana D., Sinisterra, Ruben, Cortes, Maria, Mesa, Fredy, Ramírez-Clavijo, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556714/
https://www.ncbi.nlm.nih.gov/pubmed/34760343
http://dx.doi.org/10.7717/peerj.12124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556714/
https://www.ncbi.nlm.nih.gov/pubmed/34760343
http://dx.doi.org/10.7717/peerj.12124

Ejemplares similares